NCT04033172 2019-07-25
Pyrotinib
ChineseAMS
Phase 2 Unknown
Clinical Trials
4 trialsNCT03933982 2019-05-29
Pyrotinib
ChineseAMS
Phase 2 Unknown
NCT03923166 2019-04-22
Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT03923179 2019-04-22
Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown